ArticleDiscover oncology2026
Analysis of influencing factors of lymph node metastasis in elderly patients with early gastric cancer and establishment of a prediction model.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe detection rate of early-stage gastric cancer remains relatively low. Early detection is beneficial for improving prognosis. We aim to explore the risk factors for lymph node metastasis(LNM) in elderly patients with early gastric cancer (EGC), and to construct a nomogram prediction model for validation.
methods136 patients diagnosed with elderly EGC accompanied by LNM in Cangzhou Central Hospital and Cangzhou People's Hospital from January 2021 to June 2024 were selected as the training cohort. The new gastric cancer screening score (GCSS), regenerated-protein 4(REG4), tumor abnormal protein(TAP) levels and clinicopathologic characteristics were compared in elderly EGC, gastric precancerous disease and control groups. Lasso-Logistic regression was used to identify risk factors affecting LNM, and the nomogram model was established and verified. The clinical decision curve analysis (DCA) and clinical impact curve (CIC) were performed to evaluate the model. In addition, the clinical data of 72 patients with elderly EGC who met the inclusion criteria in two hospitals from July 2024 to June 2025 were selected as the validation cohort to verify the nomogram model.
resultsThere was no statistically significant difference in general clinical data between the training cohort and the validation cohort (P > 0.05). The incidence of LNM in the training cohort was 22.79% (31/136), while that in the validation cohort was 23.61% (17/72). GCSS, REG4, and TAP levels in EGC group were higher than gastric precancerous disease group and control group. Lasso-Logistic regression showed that REG4, TAP, vascular invasion, undifferentiated type, infiltrate into the submucosa, and diameter ≥ 2 cm were independent risk factors for LNM in elderly EGC. The Nomogram model was constructed based on the independent risk factors screened out, which showed that the predicted values were in good agreement with the measured values, The area under the receiver operating characteristic curve (ROC) (AUC) of the training cohort and the validation cohort was 0.853 and 0.878, respectively. The goodness-of-fit test was conducted using the Hosmer-Lemeshow method, and the result was P = 0.751. The DCA and CIC of the training and validation cohort both indicate that the model had good clinical application value.
conclusionThe results of this study indicate that REG4, TAP, vascular invasion, undifferentiated type, infiltrate into the submucosa and diameter ≥ 2 cm are at a higher risk for LNM in elderly EGC. A nomogram model can be helpful for early prediction of LNM in elderly EGC, It provides certain references for the treatment strategies of elderly EGC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.